TROAP and neoplasm: Ye et al found that knocking down TROAP could inhibit tumor progression via activating Wnt3/survivin signaling, meanwhile induces cell cycle arrest at S phase through cyclinA2/cyclinB1 caspase pathway in prostate cancer.14